Invention Grant
- Patent Title: 2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors
-
Application No.: US14899335Application Date: 2014-06-17
-
Publication No.: US10005769B2Publication Date: 2018-06-26
- Inventor: Johann Leban , Mirko Zaja
- Applicant: 4SC DISCOVERY GMBH
- Applicant Address: DE Planegg-Martinsried
- Assignee: 4SC AG
- Current Assignee: 4SC AG
- Current Assignee Address: DE Planegg-Martinsried
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP13172577 20130618
- International Application: PCT/EP2014/062774 WO 20140617
- International Announcement: WO2014/202638 WO 20141224
- Main IPC: C07D417/14
- IPC: C07D417/14

Abstract:
The present invention relates to compounds of below Formula (I), physiologically functional derivatives or salts thereof, where the groups R1, R2, R3, R4, RA, X1, and A, as well as the variables n, m and p are detailed further herein. In another aspect, the present invention provides methods for their preparation, their medical use and pharmaceutical compositions comprising said compounds, physiologically functional derivatives, solvates or salts thereof.
Public/Granted literature
- US20160137637A1 2,3-DIHYDROBENZOFURAN-5YL COMPOUNDS AS DYRK KINASE INHIBITORS Public/Granted day:2016-05-19
Information query